Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-05-14 Purchase | 2020-05-18 4:15 pm | Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Director | 13,986 | $1.43 | $20,000 | 18,875 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-10 Other | 2021-06-14 4:10 pm | N/A 2023-06-10 | Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Former Director Director | 473,468 | $0 | 3,345,090 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 4:33 pm | 2022-05-18 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director | 200,000 | $0 | 291,050 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:16 pm | 2021-08-19 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director | 30,000 | $0 | 91,050 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:15 pm | N/A 2030-06-17 | Cardiff Oncology Inc. | CRDF | ADAMS THOMAS PHD Executive Chairman | 173,145 | $0 | 477,870 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 4:15 pm | 2021-04-03 2030-04-03 | Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director | 60,000 | $0 | 61,051 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-25 4:15 pm | 2019-07-24 2029-07-24 | Hepion Pharmaceuticals Inc. | HEPA | ADAMS THOMAS PHD Director | 970 | $0 | 1,051 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:07 pm | N/A 2029-06-20 | Trovagene Inc. | TROV | ADAMS THOMAS PHD Chief Executive Officer | 298,230 | $0 | 304,725 (Direct) | View |